Protein discovery reveals potential treatment target for common fatty liver disease
The mechanisms that cause the world's most common chronic liver disease—metabolic dysfunction-associated steatotic liver disease (MASLD)—to develop and progress are still not fully understood.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.